Martín Andrés Gaete Quiroz

Martín Andrés Gaete Quiroz

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2026 in Polymers
Verified
Journal Article
Open access
PDF file
ADAlejandro Vittorio Signorio Duque
Alejandro Vittorio Signorio Duque
LALeonardo Díaz Agurto
Leonardo Díaz Agurto
MQMartín Andrés Gaete Quiroz
Martín Andrés Gaete Quiroz
XUXavier Uriarte
Xavier Uriarte
SBSebastián Bravo
Sebastián Bravo
Daniel Torres-LagaresDaniel Torres-Lagares
Daniel Torres-Lagares
Magnesium barrier membranes have emerged as biodegradable alternatives for guided bone regeneration (GBR), but their clinical performance and implications for polymer-based designs remain uncertain. This systematic review synthesized human evidence on magnesium barriers used in implant-related GBR, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) (PROSPERO CRD420261456259). Five bibliographic databases and supplementary sources were searched; eligible studies underwent narrative synthesis, Joanna Briggs Institute appraisal, and outcome-level Grading of Recommendations Assessment, Development and Evaluation (GRADE) assessment. Sixteen publications were included, comprising case reports, case series, and observational studies; no randomized controlled trials were identified. Reported outcomes included radiographic hard tissue gains, subsequent implant placement, and satisfactory healing in selected clinical settings. However, heterogeneous protocols, limited follow-up, and concomitant interventions prevented attribution of benefits to magnesium alone. Membrane exposure and clinically detected gas were reported, although corrosion kinetics, gas composition, and long-term implant outcomes were insufficiently characterized. All 11 GRADE-assessed outcomes had very low certainty. No included clinical study evaluated an integrated polymer-coated magnesium barrier or magnesium–polymer composite membrane. Current evidence supports clinical feasibility but not comparative effectiveness. Polymer-based modifications warrant further investigation through material characterization and controlled clinical studies.